These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

11144 related items for PubMed ID: 11770702

  • 1. Anticancer activity of mycobacterial DNA: effect of formulation as chitosan nanoparticles.
    Kabbaj M, Phillips NC.
    J Drug Target; 2001; 9(5):317-28. PubMed ID: 11770702
    [Abstract] [Full Text] [Related]

  • 2. Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles.
    Tian XX, Groves MJ.
    J Pharm Pharmacol; 1999 Feb; 51(2):151-7. PubMed ID: 10217313
    [Abstract] [Full Text] [Related]

  • 3. Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex.
    Filion MC, Filion B, Reader S, Ménard S, Phillips NC.
    Cancer Immunol Immunother; 2000 Aug; 49(6):325-34. PubMed ID: 10946815
    [Abstract] [Full Text] [Related]

  • 4. Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells.
    Filion MC, Lépicier P, Morales A, Phillips NC.
    Br J Cancer; 1999 Jan; 79(2):229-35. PubMed ID: 9888462
    [Abstract] [Full Text] [Related]

  • 5. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
    Miao Y, Qiu Y, Yang W, Guo Y, Hou H, Liu Z, Zhao X.
    Colloids Surf B Biointerfaces; 2018 Sep 01; 169():313-320. PubMed ID: 29800906
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate.
    Song Y, Onishi H, Nagai T.
    Biol Pharm Bull; 1993 Jan 01; 16(1):48-54. PubMed ID: 8369752
    [Abstract] [Full Text] [Related]

  • 7. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics.
    Bozkir A, Saka OM.
    Drug Deliv; 2004 Jan 01; 11(2):107-12. PubMed ID: 15200009
    [Abstract] [Full Text] [Related]

  • 8. Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model.
    Yoncheva K, Merino M, Shenol A, Daskalov NT, Petkov PS, Vayssilov GN, Garrido MJ.
    Int J Pharm; 2019 Feb 10; 556():1-8. PubMed ID: 30529664
    [Abstract] [Full Text] [Related]

  • 9. Comparative analysis of phenotypic and genotypic characteristics of two desulfurizing bacterial strains, Mycobacterium phlei SM120-1 and Mycobacterium phlei GTIS10.
    Srinivasaraghavan K, Sarma PM, Lal B.
    Lett Appl Microbiol; 2006 May 10; 42(5):483-9. PubMed ID: 16620207
    [Abstract] [Full Text] [Related]

  • 10. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines.
    Nayak D, Minz AP, Ashe S, Rauta PR, Kumari M, Chopra P, Nayak B.
    J Colloid Interface Sci; 2016 May 15; 470():142-152. PubMed ID: 26939078
    [Abstract] [Full Text] [Related]

  • 11. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
    Gupta U, Sharma S, Khan I, Gothwal A, Sharma AK, Singh Y, Chourasia MK, Kumar V.
    Int J Biol Macromol; 2017 May 15; 98():810-819. PubMed ID: 28189791
    [Abstract] [Full Text] [Related]

  • 12. Ultrasonication of chitosan and chitosan nanoparticles.
    Tang ES, Huang M, Lim LY.
    Int J Pharm; 2003 Oct 20; 265(1-2):103-14. PubMed ID: 14522123
    [Abstract] [Full Text] [Related]

  • 13. In vivo antitumor activity of chitosan nanoparticles.
    Qi L, Xu Z.
    Bioorg Med Chem Lett; 2006 Aug 15; 16(16):4243-5. PubMed ID: 16759859
    [Abstract] [Full Text] [Related]

  • 14. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
    Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW.
    J Control Release; 2001 Feb 23; 70(3):399-421. PubMed ID: 11182210
    [Abstract] [Full Text] [Related]

  • 15. Formulation pH modulates the interaction of insulin with chitosan nanoparticles.
    Ma Z, Yeoh HH, Lim LY.
    J Pharm Sci; 2002 Jun 23; 91(6):1396-404. PubMed ID: 12115839
    [Abstract] [Full Text] [Related]

  • 16. Bacterial exopolysaccharide based nanoparticles for sustained drug delivery, cancer chemotherapy and bioimaging.
    Raveendran S, Poulose AC, Yoshida Y, Maekawa T, Kumar DS.
    Carbohydr Polym; 2013 Jan 02; 91(1):22-32. PubMed ID: 23044101
    [Abstract] [Full Text] [Related]

  • 17. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
    Kim TH, Park IK, Nah JW, Choi YJ, Cho CS.
    Biomaterials; 2004 Aug 02; 25(17):3783-92. PubMed ID: 15020154
    [Abstract] [Full Text] [Related]

  • 18. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR, Sunil D.
    Mini Rev Med Chem; 2017 Aug 02; 17(15):1457-1487. PubMed ID: 28245780
    [Abstract] [Full Text] [Related]

  • 19. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
    Mundra V, Peng Y, Kumar V, Li W, Miller DD, Mahato RI.
    Drug Deliv Transl Res; 2015 Jun 02; 5(3):199-208. PubMed ID: 25924699
    [Abstract] [Full Text] [Related]

  • 20. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY, Kim IS, Kwon IC, Kim YH.
    J Control Release; 2008 May 22; 128(1):23-31. PubMed ID: 18374444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 558.